genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2007
Wyeth Pharmaceuticals
News
Wyeth Pharmaceuticals to Continue Evaluation of Raven mAbs
News
Wyeth Takes Over Haptogen to Boost Biopharmaceutical Business
News
Antipsychotic Drug from Wyeth and Solvay Dismissed by FDA
News
First Targeted Therapy for Renal Cell Carcinoma Greenlighted
News
Wyeth Sells 10 Drugs for Almost $76.5M
News
Wyeth Pulls Out of Ibuprofen License with SCOLR
Insights
Formulation: One Ingredient for Success
News
Wyeth Inks Two Deals to Improve Hemophilia Program
News
Solvay and Wyeth Expand Collaboration to Include Neuroscience Research
News
Catalyst and Wyeth Ink Agreements Worth Up To $100M
1
2
3
4
Page 3 of 4
Scroll Up
Scroll Up
